PPAR-gamma Signaling in Normal Pilosebaceous Units and in Scarring Alopecia

正常毛囊皮脂腺单位和疤痕性脱发中的 PPAR-gamma 信号转导

基本信息

  • 批准号:
    8528334
  • 负责人:
  • 金额:
    $ 31.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-28 至 2016-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): PPAR-gamma Signaling in Normal Pilosebaceous Units (PSU) and in Scarring Alopecia ABSTRACT Primary cicatricial or scarring alopecia (CA) are characterized by a folliculocentric inflammation with the ultimate replacement of the follicle with fibrous tissue and progressive and permanent hair loss. However, the cause of the inflammatory attack and the molecular pathogenesis has yet to be elucidated. Our studies with the lymphocytic CA, Lichen planopilaris (LPP), have yielded novel results which provide clues to disease pathogenesis. We have recently shown that PPAR signaling is lost in lichen planopilaris (LPP), a lymphocytic CA, and that targeted deletion of PPAR in stem cells of the hair follicle causes scarring alopecia. However, the mechanisms responsible for loss of PPAR signaling in LPP are not understood. Our new data shows that the Aryl Hydrocarbon Receptor (AhR), best known for mediating the toxicity of dioxin, is significantly upregulated in LPP and in the PPAR KO mouse. Furthermore, a mutually antagonistic regulation exists between PPAR and AhR in hair follicle outer root sheath (ORS) cells in vitro. We show that the expression of stem cell markers (LGR5, LHX2, SOX9, TCF3) is decreased and that cytokines, growth factors and tissue remodeling genes are upregulated in LPP and in the PPAR KO mouse. We hypothesize that functional interplay of PPAR with AhR has a central role in pilosebaceous unit (PSU) homeostasis, hair follicle stem cell kinetics and disease progression in CA. The overall goals of this proposal are to elucidate the mechanisms by which AhR modulates PPAR and to delineate the mechanistic effects of this cross-talk on hair follicle outer root sheath (ORS) cells in vitro and during disease progression in scarring alopecia. We will test this hypothesis using a combination of human tissue (normal, unaffected and affected primary CA biopsies), ORS cells, the PPAR stem cell specific KO mouse model that we have developed and the K14-AhR transgenic mouse. In Aim 1, we will test the hypothesis that a mutual functional repression exists between AhR and PPAR and that aberrant PPAR signaling is involved in the pathogenesis of all CA. The focus of Aim 2 is to investigate the mechanistic effects of PPAR- AhR cross-talk on hair follicle ORS cells in vitro and its implications for scarring and fibrosis in CA. In Aim 3, we will determine the effects of stem cell specific PPAR ablation or AhR constitutive activation on the PSU and in the development of scarring alopecia. The effect of these changes on hair follicle stem cell kinetics will be investigated. The efficacy of PPAR agonists to modify immune activation toward normalcy and restore normal hair function and re-growth in the animal model will be tested. These studies provide a novel framework for understanding the role of PPAR in the pathophysiology of primary CA, they provide novel diagnostic biomarkers, facilitate the classification of clinically distinct lymphocytic and neutrophilic CA and suggest potential new therapeutic strategies, thereby addressing an important medical need. PHS 398/2590 (Rev. 11/07) Page Continuation Format Page PUBLIC HEALTH RELEVANCE: This proposal will determine if the loss of activity of the nuclear receptor, PPAR, is the cause of permanent hair loss in scarring alopecia. It will also determine whether the xenobiotic response receptor, AhR, has a role in inhibiting PPAR. PPAR has broad-range effects in controlling inflammation and regulating lipid metabolism. Because this nuclear receptor is important for normal hair follicle health, understanding its regulatory mechanisms and target effectors provides a basis for targeted therapy in hair and cutaneous diseases. PHS 398/2590 (Rev. 11/07) Page Continuation Format Page
摘要原发性瘢痕性或瘢痕性脱发(CA)以毛囊中心性炎症为特征,最终以纤维组织替代毛囊,并伴有进行性和永久性脱发。然而,炎症发作的原因和分子发病机制尚不清楚。我们对淋巴细胞CA扁平苔藓(LPP)的研究已经取得了新的结果,为疾病的发病机制提供了线索。我们最近发现,PPAR信号在扁平苔藓(LPP)(一种淋巴细胞性CA)中丢失,并且毛囊干细胞中PPAR的靶向缺失会导致瘢痕性脱发。然而,LPP中PPAR信号丢失的机制尚不清楚。我们的新数据表明,以介导二恶英毒性而闻名的芳烃受体(Aryl Hydrocarbon Receptor, AhR)在LPP和PPAR KO小鼠中显著上调。此外,PPAR和AhR在毛囊外根鞘(ORS)细胞中存在相互拮抗的调控作用。我们发现,在LPP和PPAR KO小鼠中,干细胞标志物(LGR5、LHX2、SOX9、TCF3)的表达降低,细胞因子、生长因子和组织重塑基因表达上调。我们假设PPAR与AhR的功能相互作用在CA的毛囊皮脂腺单位(PSU)稳态、毛囊干细胞动力学和疾病进展中起核心作用。本提案的总体目标是阐明AhR调节PPAR的机制,并描述这种相互作用对毛囊外根鞘(ORS)细胞在体外和瘢痕性脱发疾病进展中的机制作用。我们将使用人体组织(正常、未受影响和受影响的原发CA活检)、ORS细胞、我们开发的PPAR干细胞特异性KO小鼠模型和K14-AhR转基因小鼠来验证这一假设。在Aim 1中,我们将验证AhR和PPAR之间存在相互功能抑制的假设,以及PPAR信号异常参与所有CA的发病机制。Aim 2的重点是研究PPAR- AhR串扰对体外毛囊ORS细胞的机制作用及其对CA瘢痕和纤维化的影响。我们将确定干细胞特异性PPAR消融或AhR组成激活对PSU和瘢痕性脱发发展的影响。这些变化对毛囊干细胞动力学的影响将被研究。我们将在动物模型中测试PPAR激动剂对正常免疫激活和恢复正常头发功能和再生的功效。这些研究为理解PPAR在原发性CA病理生理中的作用提供了一个新的框架,它们提供了新的诊断生物标志物,促进了临床不同淋巴细胞性和中性粒细胞性CA的分类,并提出了潜在的新治疗策略,从而解决了重要的医疗需求。小灵通398/2590 (Rev. 11/07)页延续格式页

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kevin D Cooper其他文献

1993 Annual Dermatology Foundation Winter Colloquium
  • DOI:
    10.1111/1523-1747.ep12616656
  • 发表时间:
    1992-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Lawrence S Chan;Craig. Harnmerberg;Kefei. Kang;Patricia. Sabb;Amir. Tavakkol;Kevin D Cooper
  • 通讯作者:
    Kevin D Cooper
Maximizing the Potential of Biobanks in Dermatology Research
最大限度地发挥生物样本库在皮肤病学研究中的潜力
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. M. Treichel;Jacky HK Chen;Samantha Epstein;Thomas S. McCormick;J. Bordeaux;David J Alouani;Kevin D Cooper
  • 通讯作者:
    Kevin D Cooper

Kevin D Cooper的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kevin D Cooper', 18)}}的其他基金

Psoriasis Center of Research Translation
银屑病研究翻译中心
  • 批准号:
    10005116
  • 财政年份:
    2017
  • 资助金额:
    $ 31.89万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10005118
  • 财政年份:
    2017
  • 资助金额:
    $ 31.89万
  • 项目类别:
Psoriasis Center of Research Translation
银屑病研究翻译中心
  • 批准号:
    10259872
  • 财政年份:
    2017
  • 资助金额:
    $ 31.89万
  • 项目类别:
Psoriasis Center of Research Translation
银屑病研究翻译中心
  • 批准号:
    9370683
  • 财政年份:
    2017
  • 资助金额:
    $ 31.89万
  • 项目类别:
Psoriasis Center of Research Translation
银屑病研究翻译中心
  • 批准号:
    9792242
  • 财政年份:
    2017
  • 资助金额:
    $ 31.89万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10259873
  • 财政年份:
    2017
  • 资助金额:
    $ 31.89万
  • 项目类别:
Psoriatic Regulatory T cell Dysfunction
银屑病调节性 T 细胞功能障碍
  • 批准号:
    8683592
  • 财政年份:
    2013
  • 资助金额:
    $ 31.89万
  • 项目类别:
S100 A8/A9 and Macrophages in Psoriasis
银屑病中的 S100 A8/A9 和巨噬细胞
  • 批准号:
    8319618
  • 财政年份:
    2011
  • 资助金额:
    $ 31.89万
  • 项目类别:
S100 A8/A9 and Macrophages in Psoriasis
银屑病中的 S100 A8/A9 和巨噬细胞
  • 批准号:
    7928965
  • 财政年份:
    2009
  • 资助金额:
    $ 31.89万
  • 项目类别:
PPAR-gamma Signaling in Normal Pilosebaceous Units and in Scarring Alopecia
正常毛囊皮脂腺单位和疤痕性脱发中的 PPAR-gamma 信号转导
  • 批准号:
    8735236
  • 财政年份:
    2009
  • 资助金额:
    $ 31.89万
  • 项目类别:

相似海外基金

Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
  • 批准号:
    24K21101
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
  • 批准号:
    24K11201
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
  • 批准号:
    24K11281
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
  • 批准号:
    EP/Z001145/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Fellowship
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
  • 批准号:
    2338890
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334777
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334775
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334776
  • 财政年份:
    2024
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Continuing Grant
Cryo laser-ablation system (157+193nm) with 'triple-quad' plasma mass spectrometer, Cryo-LA-ICPMS/MS
带有“三重四极杆”等离子体质谱仪、Cryo-LA-ICPMS/MS 的冷冻激光烧蚀系统 (157 193nm)
  • 批准号:
    515081333
  • 财政年份:
    2023
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Major Research Instrumentation
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
  • 批准号:
    2320040
  • 财政年份:
    2023
  • 资助金额:
    $ 31.89万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了